Symmetric Capital
Symmetric Capital is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Symmetric Capital.
Symmetric Capital is a company.
Key people at Symmetric Capital.
Key people at Symmetric Capital.
Symmetric Capital is a private equity firm founded in 1990, headquartered in Waltham, Massachusetts, that partners with profitable growth companies in the US and Canada.[1][2] It manages over $200 million in committed capital, investing $5-25 million per company in equity to support liquidity for selling shareholders, working capital, or acquisitions, while allowing management teams to retain operational control and significant equity upside.[1] The firm's investment philosophy emphasizes value-added partnerships that preserve entrepreneurial culture without excessive debt or change of control, drawing on a track record of over 40 investments since 1990 that have helped raise more than $1.2 billion in capital across diverse industries.[1] Key sectors include business services, manufacturing (e.g., aircraft components, medical textiles), and education-related services, with notable portfolio companies like Belkin International, Biomedical Structures, and Somero Enterprises.[1][2]
Symmetric Capital traces its roots to 1990, when its principals began investing in growth companies, evolving into a formalized private equity firm focused on profitable US and Canadian businesses.[1][2] Key partners include Co-Founders and Managing Partners Daniel K. Doyle and Robert V. Walsh, alongside Chief Financial Officer Mary Murphy Westover, operating from their Waltham office since at least 2006 as an SEC-registered investment adviser owned by its principals.[3][5] The firm has grown from early investments in over 40 companies to managing funds like Symmetric Partners LP with $202 million committed, adapting a flexible model for minority or majority positions amid shifting market dynamics in private equity.[1][5]
Symmetric Capital rides the wave of growth equity in profitable mid-market companies, particularly in business services and manufacturing-adjacent tech like medical biomaterials (Biomedical Structures) and connectivity (Belkin, TekLinks), amid a private equity shift toward resilient, cash-flow-positive firms post-2020 economic volatility.[1][2] Timing aligns with favorable market forces such as lower interest rates enabling equity deals and demand for flexible capital in fragmented US/Canada sectors, where family-owned or founder-led businesses seek partners without ceding control.[1] The firm influences the ecosystem by enabling serial acquisitions and scaling (e.g., School Improvement Network), bridging traditional PE with growth-stage needs and fostering operator-led expansion in non-venture tech niches.[1]
Symmetric Capital is poised to capitalize on mid-market consolidation, potentially expanding its $200M+ AUM through new funds targeting tech-enabled services amid economic recovery.[1][5] Trends like supply chain resilience and M&A rebound will shape its path, with influence evolving toward deeper operating roles in portfolio firms navigating inflation and tech integration. As a steady partner for proven teams, it stands out in a crowded PE field—much like its founding mission to unlock equity value without upending success.
